A Review of Slimona

If you are overweight and looking for a solution, Slimona may be the diet supplement for you. Also known by the names Rimonabant, Acomplia, Riobant, Rimoslim, and Zimulti, this diet supplement is one of the newest ways that dieters can achieve their weight loss goals.

What makes Slimona Different?

Slimona is the first diet pill that has been approved for use and that blocks CB1 receptors. Used in Europe, Slimona has been shown at being effective at helping overweight patients with a Body Mass Index, or BMI of 30 or more. Slimona has not yet been approved for sale in the United States.

How Slimona works

Slimona blocks CB1 receptors in the brain. Part of the physiological system known as the Endocannabinoid System, these receptors are thought to play a role in appetite and how your body regulates the amount of food that it takes in and how it spends its energy. In people who smoke marijuana, these receptors are thought to be responsible for the feelings of “munchies” that the person gets after smoking. Besides the brain, these receptors can also be found in fat cells throughout the body. These receptors are also thought to be responsible for addictions to other behaviors, such as smoking and the addiction to nicotine.

A look at cannabinoids

Cannabinoids are the chemical compounds that latch on to these CB1 receptors. In patients who are overweight and obese, these receptors tend to be overactive, causing them to feel an increased desire to eat. In 2001, a study looking at mice that had been genetically altered to not have cannabinoid receptors was found to eat significantly less than other mice – even if the mice fasted beforehand. When Slimona was administered to normal mice, these mice also reduced their food consumption. With such promising results, this prompted the development of Slimona for use in people.

Why the excitement over Slimona

Besides the fact that Slimona has been shown to help patients lose some of their cravings for food and other addictive substances, many researchers are also excited about the drug for other reasons. When looked at in comparison to overall body mass, Slimona had only average results as far as achieving weight loss. However, besides helping patients lose weight, Slimona also helped improve the patient's risk factors for cardiovascular diseases and other health problems. Patients taking Slimona saw an increase in their good cholesterol and a decrease in their triglycerides. They also saw improved blood sugar levels. In one study of Slimona, approximately 50% of the patients taking the trial that had metabolic syndrome at the start did not have it when the trial was concluded two years later. These findings alone were enough for some European doctors to consider Slimona as an option for their overweight patients.
For patients that have a significant amount of weight to lose, and for patients that have weight-related health problems, Slimona could be the answer that they are looking for. When used with a sensible diet and exercise program, patients taking Slimona can see an improvement in overall health as well as weight loss.